JP2024521869A - 前立腺癌診断用バイオマーカー及びその使用 - Google Patents

前立腺癌診断用バイオマーカー及びその使用 Download PDF

Info

Publication number
JP2024521869A
JP2024521869A JP2023573568A JP2023573568A JP2024521869A JP 2024521869 A JP2024521869 A JP 2024521869A JP 2023573568 A JP2023573568 A JP 2023573568A JP 2023573568 A JP2023573568 A JP 2023573568A JP 2024521869 A JP2024521869 A JP 2024521869A
Authority
JP
Japan
Prior art keywords
mir
hsa
mirna
prostate cancer
lncrna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023573568A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521869A5 (https=
Inventor
クワン ヨン チェ
ジョン ミン キム
テ ヤン ホ
Original Assignee
シスバイオジェン カンパニー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シスバイオジェン カンパニー リミテッド filed Critical シスバイオジェン カンパニー リミテッド
Publication of JP2024521869A publication Critical patent/JP2024521869A/ja
Publication of JP2024521869A5 publication Critical patent/JP2024521869A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2023573568A 2021-05-28 2022-05-30 前立腺癌診断用バイオマーカー及びその使用 Pending JP2024521869A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2021-0069428 2021-05-28
KR1020210069428A KR102550113B1 (ko) 2021-05-28 2021-05-28 전립선암 진단용 바이오마커 및 이의 용도
PCT/KR2022/007695 WO2022250517A1 (ko) 2021-05-28 2022-05-30 전립선암 진단용 바이오마커 및 이의 용도

Publications (2)

Publication Number Publication Date
JP2024521869A true JP2024521869A (ja) 2024-06-04
JP2024521869A5 JP2024521869A5 (https=) 2024-06-11

Family

ID=84229115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023573568A Pending JP2024521869A (ja) 2021-05-28 2022-05-30 前立腺癌診断用バイオマーカー及びその使用

Country Status (5)

Country Link
US (1) US20250283176A1 (https=)
EP (1) EP4365310A4 (https=)
JP (1) JP2024521869A (https=)
KR (2) KR102550113B1 (https=)
WO (1) WO2022250517A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102414106B1 (ko) * 2020-03-12 2022-06-29 (주) 바이오인프라생명과학 유방암 진단용 다중 바이오마커 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013526852A (ja) * 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
US10801072B2 (en) * 2014-09-04 2020-10-13 Miodx Method of analysis allowing avoidance of surgery
ES2749651T3 (es) * 2015-02-11 2020-03-23 Region Midtjylland Método basado en microARN para la detección temprana de cáncer de próstata en muestras de orina

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102414106B1 (ko) * 2020-03-12 2022-06-29 (주) 바이오인프라생명과학 유방암 진단용 다중 바이오마커 및 이의 용도

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
FILIPPO MARTIGNANO: "Urinary RNA-based biomarkers for prostate cancer detection", CLINICA CHIMICA ACTA, vol. ４７３, JPN6025023823, 12 August 2017 (2017-08-12), pages 96 - 105, ISSN: 0005626010 *
FUMIHIKO URABE: "Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer", CLIN CANCER RES, vol. 25(10), JPN6025023824, 26 February 2019 (2019-02-26), pages 3016 - 3025, ISSN: 0005626012 *
JACOB FREDSOE: "Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine", EUROPEAN UROLOGY FOCUS, vol. 4, JPN6025023343, 9 March 2017 (2017-03-09), pages 825 - 833, ISSN: 0005626011 *
KATI P. PORKKA: "MicroRNA Expression Profiling in Prostate Cancer", CANCER RES, vol. 67:(13), JPN6025023826, 1 July 2007 (2007-07-01), pages 6130 - 6135, ISSN: 0005626014 *
XUEPING ZHANG: "MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade p", CLIN EXP METASTASIS, vol. ２６, JPN6025023825, 22 September 2009 (2009-09-22), pages 965 - 979, ISSN: 0005626013 *

Also Published As

Publication number Publication date
EP4365310A4 (en) 2025-12-17
EP4365310A1 (en) 2024-05-08
KR102550113B1 (ko) 2023-07-03
KR20230106542A (ko) 2023-07-13
WO2022250517A1 (ko) 2022-12-01
US20250283176A1 (en) 2025-09-11
KR20220161039A (ko) 2022-12-06

Similar Documents

Publication Publication Date Title
JP2019522478A (ja) 遺伝子発現プロファイルを用いた肺癌の診断のための組成物及び方法
CN114875139B (zh) 包括外泌体miR-106b-3p、let-7a-3p等在肺癌诊断中的应用
US20230257826A1 (en) Methods for predicting prostate cancer and uses thereof
CN101855348A (zh) 肝癌相关基因、以及肝癌风险的判定方法
CN114916233A (zh) 泛癌症早筛预测方法
CN111424085B (zh) tRNA来源片段在制备乳腺癌诊断试剂中的应用
CN110229899B (zh) 用于结直肠癌早期诊断或预后预测的血浆标记物组合
US20230399703A1 (en) Cancer examination reagent set, production method for cancer examination reagent set, and cancer examination method
Chen et al. Fecal miRNAs as potential biomarkers for early detection of colorectal cancer: An updated review
WO2011146937A1 (en) Methods and kits useful in diagnosing nsclc
BR112020012280A2 (pt) composições e métodos para diagnosticar cânceres de pulmão usando perfis de expressão de gene
KR102052398B1 (ko) 전립선암 진단용 바이오마커 및 이의 용도
JP2024521869A (ja) 前立腺癌診断用バイオマーカー及びその使用
TWI854510B (zh) 基於液態活檢的癌症早期篩檢方法
CN118995931A (zh) LncRNA AC113143.1作为结肠癌诊断标志物的应用
WO2020135422A1 (zh) 健康风险评估方法
CN114480636B (zh) 胆汁细菌作为肝门部胆管癌诊断及预后标志物的用途
CN113444805B (zh) 检测组织中tRF表达引物在制备喉癌辅助诊断试剂盒的应用
WO2024174260A1 (zh) 基于液态活检的癌症早期筛检方法
CN110343761B (zh) 前列腺癌的标志物组及其应用
CN118922561A (zh) 肾癌诊断用尿液miRNA标志物、诊断试剂及试剂盒
CN118414427A (zh) 前列腺癌诊断用尿液miRNA标志物、诊断试剂及试剂盒
WO2022084170A1 (en) Method for differential diagnosis of prostate disease and marker for differential diagnosis of prostate disease as well as kit therefor
CN112176060B (zh) 一组血浆非编码rna及检测其表达水平的引物组与结直肠癌检测试剂盒
US11676724B1 (en) Method of calculating diagnostic score for prostate cancer and use thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240528

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240528

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250624

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250917

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260224